A benzenesulfonamide derivative as a novel PET radioligand for CXCR4.

Bioorg Med Chem

Department of Radiation Oncology, Emory University School of Medicine, USA; Department of Radiology and Image Sciences, Emory University School of Medicine, USA; Winship Cancer Institute, Atlanta, GA 30322, USA. Electronic address:

Published: January 2020

CXCR4 is involved in various diseases such as inflammation, tumor growth, and cancer metastasis through the interaction with its natural endogenous ligand, chemokine CXCL12. In an effort to develop imaging probes for CXCR4, we developed a novel small molecule CXCR4-targeted PET agent (compound 5) by combining our established benzenesulfonamide scaffold with a labeling component by virtue of click chemistry. 5 shows nanomolar affinity (IC = 6.9 nM) against a known CXCR4 antagonist (TN14003) and inhibits more than 65% chemotaxis at 10 nM in vitro assays. Radiofluorinated compound 5 ([F]5) demonstrates a competitive cellular uptake against CXCL12 in a dose-dependent manner. Further, microPET images of [F]5 exhibits preferential accumulation of radioactivity in the lesions of λ-carrageenan-induced paw edema, human head and neck cancer orthotopic xenograft, and metastatic lung cancer of each mouse model.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942325PMC
http://dx.doi.org/10.1016/j.bmc.2019.115240DOI Listing

Publication Analysis

Top Keywords

benzenesulfonamide derivative
4
derivative novel
4
novel pet
4
pet radioligand
4
cxcr4
4
radioligand cxcr4
4
cxcr4 cxcr4
4
cxcr4 involved
4
involved diseases
4
diseases inflammation
4

Similar Publications

Carbonic anhydrases (CAs) IX and XII are crucial for the survival and metastasis of solid tumors under hypoxic conditions. We designed compounds -, integrating triazole and benzenesulfonamide scaffolds known for inhibiting tumor-associated CAs IX/XII. Initial synthesis included compounds -, followed by diversification with small hydrophobic groups (-) and hydrophilic heterocyclic secondary amines (-).

View Article and Find Full Text PDF

This study is focused on the design, synthesis, and evaluation of some sulfonamide derivatives for their inhibitory effects on human carbonic anhydrase (hCA) enzymes I, II, IX, and XII as well as for their antioxidant activity. The purity of the synthesized molecules was confirmed by the HPLC purity analysis and was found in the range of 93%-100%. The inhibition constant (K) against hCA I ranged from 0.

View Article and Find Full Text PDF

This study reports the design, synthesis, and characterization of a novel series of benzene sulfonamide-triazole hybrid derivatives, to evaluate their anticancer potential against colorectal cancer. The synthesized compounds were characterized using NMR and HRMS spectroscopic techniques. In vitro cytotoxicity assessments revealed that compounds 5g and 5j exhibited significant anticancer effects.

View Article and Find Full Text PDF

[Sorption and Transport of Antibiotics in Manured Upland Agricultural Soils].

Huan Jing Ke Xue

January 2025

State Key Laboratory of Subtropical Silviculture, College of Forestry and Biotechnology, Zhejiang A&F University, Hangzhou 311300, China.

Sorption and transport are important environmental behaviors of antibiotics in soils and can determine the fate of antibiotics in environments; however, limited relevant studies have been conducted on long-term manured soils. In this study, batch and repacked soil column experiments were conducted to examine the sorption and transport behavior of four veterinary antibiotics, including sulfamethazine (SMT), florfenicol (FFC), doxycycline (DOX), and enrofloxacin (ENR), in red soils, yellow soils, and calcareous soils with long-term amendment of chicken or pig manure collected in Zhejiang Province. The results showed that the sorption isothermal data of the four target antibiotics all conformed well to the linear and Freundlich models.

View Article and Find Full Text PDF

Anti-inflammatory and antinociceptive effects of LQFM275 - A new multi-target drug.

Int Immunopharmacol

January 2025

Laboratory of Pharmacology of Natural and Synthetic Products, Institute of Biological Sciences, Federal University of Goiás, Campus Samambaia, Goiânia, Brazil.

Compound (4-(3,5-di-tert-butyl-4-hydroxybenzylamine)benzenesulfonamide) (LQFM275) was designed and synthesized from darbufelone and sulfanilamide as a new multi-target for the treatment of inflammatory diseases. LQFM275 showed a great range of safe cytotoxicity profile (100-400 μM) evaluated by MTT assay, preventing damage induced by lipopolysaccharide (LPS) in EA.hy926 cell line.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!